{"id":731,"date":"2026-05-26T18:52:06","date_gmt":"2026-05-26T09:52:06","guid":{"rendered":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/?p=731"},"modified":"2026-05-26T18:52:56","modified_gmt":"2026-05-26T09:52:56","slug":"%e4%ba%88%e6%b8%ac%e3%81%a0%e3%81%91%e3%81%a7%e7%b5%82%e3%82%8f%e3%82%89%e3%81%aa%e3%81%84%e6%b2%bb%e7%99%82%e3%82%82%e5%a4%89%e3%81%88%e3%82%8b%e8%82%9d%e3%81%8c%e3%82%93%e5%85%8d%e7%96%ab%e7%99%82","status":"publish","type":"post","link":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/news\/2026\/05\/26\/731\/","title":{"rendered":"Discovery of a biomarker that not only predicts but also changes treatment (Dr. Yu Sato, Dr. Kodama) [JITC]."},"content":{"rendered":"<p>A research group led by Dr. Yu Sato (graduate student) and Dr. Naohiro Kodama (professor) has found that pretreatment blood CA9 concentration is a biomarker to predict therapeutic efficacy of atezolizumab\/bevacizumab, the standard first-line therapy for unresectable hepatocellular carcinoma*3, and also found that CA9 molecules may be involved in treatment resistance. In addition, we found that the CA9 molecule may be involved in the resistance to treatment.<\/p>\n<p>The results of this research were published online in the Journal for ImmunoTherapy of Cancer, the journal of the American Association for Immunotherapy of Cancer, on Thursday, April 9, 2026.<\/p>\n<p>For more information.<a href=\"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/activities\/results\/2026year\/sato2026-5-26\/\" style=\"color: blue; text-decoration: underline;\">Press release here<\/a>Please see from<\/p>","protected":false},"excerpt":{"rendered":"<p>\u4f50\u85e4\u60a0\u5148\u751f\uff08\u5927\u5b66\u9662\u751f\uff09\u3001\u5c0f\u7389\u5c1a\u5b8f\u5148\u751f\uff08\u6559\u6388\uff09\u3089\u306e\u7814\u7a76\u30b0\u30eb\u30fc\u30d7\u304c\u3001\u5207\u9664\u4e0d\u80fd\u809d\u7d30\u80de\u304c\u3093\u203b3\u306b\u5bfe\u3059\u308b\u6a19\u6e96\u4e00\u6b21\u6cbb\u7642\u3067\u3042 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"post_folder":[],"class_list":["post-731","post","type-post","status-publish","format-standard","hentry","category-pressrelease"],"_links":{"self":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/posts\/731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/comments?post=731"}],"version-history":[{"count":4,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/posts\/731\/revisions"}],"predecessor-version":[{"id":736,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/posts\/731\/revisions\/736"}],"wp:attachment":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/media?parent=731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/categories?post=731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/tags?post=731"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/post_folder?post=731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}